US · Healthcare

Evelo Biosciences Inc (EVLO)

Biotechnology

Evelo Biosciences Inc (EVLO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for EVLO

P/E ratio

25.00

Evelo Biosciences Inc (EVLO) — FAQ

What is EVLO's P/E ratio?

The price-to-earnings (P/E) ratio for Evelo Biosciences Inc (EVLO) is 25.00 (data as of 2026-05-23).

Does Evelo Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Evelo Biosciences Inc (EVLO). Check the MyAverix Finance app for the latest dividend data.

What sector is Evelo Biosciences Inc in?

Evelo Biosciences Inc (EVLO) is classified in the Healthcare sector (Biotechnology industry).

What exchange is EVLO listed on?

EVLO is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)